News-Medical.Net November 4, 2024
New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility and pain relief.
In a recent study published in The New England Journal of Medicine, researchers used a 68-week-long, extensive (61 centers across 11 countries), randomized clinical trial to evaluate Semaglutide‘s pain- and weight-relieving performance in overweight arthritis patients.
A once-weekly 2.4 mg subcutaneous injection of the novel antidiabetic wonder drug was observed to reduce body weight (13.7%) and pain (WOMAC = 41) substantially more than similar placebo dosages (3.2% and 27.5 points, respectively).
Semaglutide consumption almost doubles physical function gains compared to placebo (12.0 versus 6.5 points), further promoting somatic health, weight loss, and healthy aging. Safety was similar between case...
Today's Sponsors
Today's Sponsor